JB Chemicals & Pharmaceuticals Quarterly Results

Charts

YoY Net Sales (Quarterly)

Operating Margin

EPS Growth

POSITIVES

Revenue growth of 10.5% in the latest quarter indicates strong demand and market positioning.
Profit margins improved significantly, reflecting efficient cost management and operational excellence.
Consistent cash flow from operations enhances financial stability for future investments.

NEGATIVES

Revenue decline of 2.6% compared to the previous quarter raises concerns about sales sustainability.
Net profit decreased from ₹174.57 Crore to ₹162.49 Crore, indicating profitability challenges.
Operating profit margin decline suggests potential issues in cost control or pricing strategy.

Field	Sep 23	Dec 23	Mar 24	Jun 24	Sep 24	Dec 24	Mar 25	Jun 25
Revenue	881.74	844.51	861.73	1,004.40	1,000.62	963.49	949.48	1,093.94
Expenses	680.74	667.91	713.76	770.45	774.04	753.50	770.93	836.88
Operating Profit	201	176.60	147.97	233.95	226.58	209.99	178.55	257.06
Other Income	7.66	7.35	16.63	5.89	9.95	8	14.48	14.55
Interest	10.37	12.49	9.41	5.64	2.06	2.58	1.45	1.11
Depreciation	32.17	34.03	40.74	40.78	41.88	41.94	46.44	42.70
Profit Before Tax	208.66	183.95	164.60	239.84	236.53	217.99	193.03	271.61
Tax	58.07	50.38	38.44	63.01	61.96	55.50	47.34	69.23
Net Profit	150.59	133.57	126.16	176.83	174.57	162.49	145.69	202.38
Eps in Rs	9.72	8.62	8.22	11.39	11.24	10.46	9.36	12.99